Rhythm-guided blood thinner strategy after AF ablation and stenting
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a rhythm-guided approach to using blood thinners (antithrombotics) is safe and effective for people who have had both a heart stent and a successful ablation for atrial fibrillation. It may help you avoid unnecessary medication while preventing strokes and bleeds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had a successful catheter ablation for atrial fibrillation 3 to 6 months ago, and your heart has stayed in normal rhythm since.
- You have had a heart stent placed (PCI with a drug-eluting stent) and finished the recommended time on dual antiplatelet therapy.
- You are currently taking a NOAC blood thinner (such as apixaban, rivaroxaban, edoxaban, or dabigatran).
- You are stable enough for your doctor to consider adjusting your blood thinner medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different blood-thinner (“antithrombotic”) strategies in people with atrial fibrillation or flutter who recently had a stent placed (PCI). It aims to find a plan that lowers clot risk while keeping bleeding risk as low as possible.
This trial tests whether people with atrial fibrillation who have had a successful ablation procedure can safely stop taking blood thinners (NOACs) if they wear a monitor to check for any silent heart rhythm problems. It may help you avoid the risks of long-term blood thinner use if your ablation has been effective.
This trial tests whether taking a single “P2Y12 inhibitor” blood thinner (instead of multiple medicines) is safe and effective after you get a coronary stent. It’s for people with atrial fibrillation who need long-term blood thinning and have recently had a successful stent procedure.
This trial compares blood thinner and antiplatelet treatments in people with atrial fibrillation (AF) and stable but high-risk coronary artery disease (CAD). The goal is to find the safest way to prevent strokes and heart attacks.
This trial tests whether it is safe to stop taking blood thinners (anticoagulants) after a successful ablation procedure for atrial fibrillation. If you have had no AF for 3 months after your first ablation, you may be able to stop these medications, reducing your risk of bleeding.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.